CN Patent

CN115974799B — 氨基甲酸酯取代的醇衍生物及其在医药上的应用

Assigned to Kangbaida Sichuan Biopharmaceutical Technology Co ltd · Expires 2024-08-13 · 2y expired

What this patent protects

本发明涉及一种氨基甲酸酯取代的醇衍生物、其立体异构体或者药学上可接受的盐,及其在医药上的应用。

USPTO Abstract

本发明涉及一种氨基甲酸酯取代的醇衍生物、其立体异构体或者药学上可接受的盐,及其在医药上的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN115974799B
Jurisdiction
CN
Classification
Expires
2024-08-13
Drug substance claim
No
Drug product claim
No
Assignee
Kangbaida Sichuan Biopharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.